Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
boston blog main
boston top stories
6
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
6
×
gene therapy
hemophilia
san francisco blog main
san francisco top stories
deals
san diego blog main
san diego top stories
biotech
boulder/denver blog main
boulder/denver top stories
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
sangamo therapeutics
seattle blog main
seattle top stories
spark therapeutics
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
biomarin pharmaceutical
bluebird bio
celgene
fda
novartis
pfizer
What
gene
6
×
therapy
6
×
bio
roundup
drug
help
long
moves
past
patients
race
advanced
age
alnylam’s
approval
aren’t
becker
bff
bigger
biggest
billions
close
come
conference
crude
cutting
data
deal
deals
despite
developers
devoted
disease
dollars
drugs
easl
eaton
edge
effects
emerging
Language
Current search:
therapy
×
photo
×
" boston top stories "
×
gene
×
" new york top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
4 years ago
With Data, Pfizer/Sangamo Step Forward in Hemophilia Gene Therapy Race
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More